In all 40 neuroblastoma samples, GUSB was detectable; for patients with localized disease, the mean was 38.2 copies/mL plasma (range 2.3–95 copies/mL plasma) and metastatic disease, 53 copies/mL plasma (range 10–220 copies/mL plasma). Here, GUSB is linked to metastatic neoplasm.